Showing results (1-10 of 406) with videos related to
Sort By:
Pageof 41
Current Opinion in Immunology|January 17, 2012
Modulation of GITR for cancer immunotherapyDavid A Schaer, Judith T Murphy, Jedd D WolchokJournal for Immunotherapy of Cancer|May 24, 2014
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapyDavid A Schaer, Daniel Hirschhorn-Cymerman, Jedd D WolchokThe Journal of Experimental Medicine|September 28, 2011
Hiding the road signs that lead to tumor immunityDavid A Schaer, Alexander M Lesokhin, Jedd D WolchokCurrent Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Anti-GITR antibodies--potential clinical applications for tumor immunotherapyDavid A Schaer, Adam D Cohen, Jedd D WolchokClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor typesPaolo A Ascierto, Michael Kalos, David A Schaer, et al.Journal of Translational Medicine|April 20, 2004
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesRoopa Srinivasan, Jedd D WolchokCurrent Opinion in Immunology|April 9, 2013
Combining cancer immunotherapy and targeted therapyAntoni Ribas, Jedd D WolchokThe Oncologist|November 15, 2008
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activationJedd D Wolchok, Yvonne SaengerPageof 41